medigraphic.com
ISSN 2007-6800 (Print)

2019, Number 1

<< Back

Rev Mex Traspl 2019; 8 (1)

Renal transplant in patient with human immunodeficiency virus infection. A case report

Bahena-Carrera L, Martínez-Íñiguez JM, Ramos-Díaz EE, Gómez-Vázquez JA, Jiménez-Chavarría E, Loera-Torres MA, Mendiola FR, Muñoz-Arce CM, Hernández-Díaz S, Noyola-Villalobos HF

Language: Spanish
References: 13
Page: 37-41
PDF size: 231.57 Kb.


ABSTRACT

Introduction: With the appearance of antiretrovirals to improve the survival of patients with human immunodeficiency virus (HIV) seropositive with consequent increase in risk factors to develop chronic kidney disease. There are reports of cases of kidney transplants since 1980 in the pre-antiretroviral era with sub-optimal results that have improved since 1996. Clinical case: A 31-year-old male with a diagnosis of chronic kidney disease of etiology not determined in 2013 and HIV in 2014. The case for transplantation was accepted the end of 2018, efavirenz was previously substituted for raltegravir. The preoperative studies were: hemoglobin 8.7 g/dL, leukocytes 6,870 × 10³/µL, creatinine 12.7 mg/dL, urea 171.2 mg/dL, undetectable viral load and CD4 count 611/mm³. Warm ischemia time of 40 minutes, cold ischemia time 15 minutes. The immunosuppression induction with CD-25, tacrolimus, mycophenolic acid and steroid, the patient was discharged on the eighth day with creatinine of 1 mg/dL, Hb 8.78 g/dL, leukocytes 6,870 × 10³/µL, tacrolimus levels 6.1 ng/mL. The glomerular filtration rate at two months post-transplant is 103 mL/min/1.73 m2 and his follow-up without surgical, medical or infectious complications.


REFERENCES

  1. Axelrod DA, Schnitzler MA, Xiao H et al. An economic assessment of contemporary kidney transplant practice. Am J Transplant. 2018; 18: 1168-1176.

  2. Locke JE, Gustafson S, Mehta S et al. Survival benefit of kidney transplantation in HIV-infected patients. Ann Surg. 2017; 265 (3): 604-608.

  3. Trullás JC, Miró JM, Barril G et al. Trasplante renal en pacientes infectados por el VIH. Enferm Infecc Microbiol Clin. 2005; 23 (6): 363-374.

  4. Registro Nacional de Casos de SIDA. [Internet]. 2018. Available in https://www.gob.mx/cms/uploads/attachment/file/415154/RN_D_a_mudial_sida2018.pdf.

  5. Bhagani S, Sweny PI. Guidelines for kidney transplantation in patients with HIV disease. HIV Med. 2006; 7: 133-139.

  6. Stock PG, Barin B, Murphy B et al. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med. 2010; 363: 2004-2014.

  7. Cohen SD, Kopp JB, Kimmel PL. Kidney diseases associated with human immunodeficiency virus infection. New Engl J Med. 2017; 377 (24): 2363-2374.

  8. Rosenberg AZ, Naicker S, Winkler CA, Kopp JB. HIV-associated nephropathies: epidemiology, pathology, mechanisms and treatment. Nat Rev Nephrol. 2015; 11: 150-160.

  9. Vicari AR, Spuldaro F, Sandes-Freitas TV et al. Renal transplantation in human immunodeficiency virus-infected recipients: a case-control study from the Brazilian experience. Transpl Infect Dis. 2016; 18 (5): 730-740. doi: 10.1111/tid.12592.

  10. Cristelli MP, Cofán F, Tedesco-Silva H et al. Regional differences in the management and outcome of kidney transplantation in patients with human immunodeficiency virus infection: a 3-year retrospective cohort study. Transpl Infect Dis. 2017; 19 (4). doi: 10.1111/tid.12724.

  11. Locke JE, Shelton BA, Reed RD et al. Identification of optimal donor–recipient combinations among human immunodeficiency virus (HIV)-positive kidney transplant recipients. Am J Transplant. 2016; 16: 2377-2383.

  12. Locke JE, Mehta S, Reed RD et al. A national study of outcomes among HIV-infected kidney transplant recipients. J Am Soc Nephrol. 2015; 26: 2222-2229.

  13. Locke JE, Reed RD, Mehta SG. Center-level experience and kidney transplant outcomes in HIV-infected recipients. Am J Transplant. 2015; 15: 2096-2104.




2020     |     www.medigraphic.com